- Home
- ADUS vs RCKT Comparison
ADUS vs RCKT Comparison
Compare ADUS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADUS
- RCKT
- Stock Information
- Founded
- ADUS 1979
- RCKT 1999
- Country
- ADUS United States
- RCKT United States
- Employees
- ADUS N/A
- RCKT N/A
- Industry
- ADUS Medical/Nursing Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ADUS Health Care
- RCKT Health Care
- Exchange
- ADUS Nasdaq
- RCKT Nasdaq
- Market Cap
- ADUS 2.1B
- RCKT 326.4M
- IPO Year
- ADUS 2009
- RCKT N/A
- Fundamental
- Price
- ADUS $111.86
- RCKT $2.90
- Analyst Decision
- ADUS Buy
- RCKT Buy
- Analyst Count
- ADUS 10
- RCKT 13
- Target Price
- ADUS $143.50
- RCKT $18.50
- AVG Volume (30 Days)
- ADUS 162.0K
- RCKT 4.3M
- Earning Date
- ADUS 08-04-2025
- RCKT 08-04-2025
- Dividend Yield
- ADUS N/A
- RCKT N/A
- EPS Growth
- ADUS 9.84
- RCKT N/A
- EPS
- ADUS 4.42
- RCKT N/A
- Revenue
- ADUS $1,211,561,000.00
- RCKT N/A
- Revenue This Year
- ADUS $23.16
- RCKT N/A
- Revenue Next Year
- ADUS $5.77
- RCKT N/A
- P/E Ratio
- ADUS $25.33
- RCKT N/A
- Revenue Growth
- ADUS 11.38
- RCKT N/A
- 52 Week Low
- ADUS $88.96
- RCKT $2.19
- 52 Week High
- ADUS $136.72
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- ADUS 47.70
- RCKT 41.69
- Support Level
- ADUS $112.34
- RCKT $2.40
- Resistance Level
- ADUS $117.03
- RCKT $2.70
- Average True Range (ATR)
- ADUS 2.75
- RCKT 0.21
- MACD
- ADUS -0.59
- RCKT 0.15
- Stochastic Oscillator
- ADUS 26.46
- RCKT 73.53
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.